Information de reference pour ce titreAccession Number: | 00132577-200812000-00001.
|
Author: | Goyal, Neil MD *+; Stant, Jennifer NP +; Esposito, Francesca NP +; Piri, Gina NP +; Collins, Michael MD *+; Sayan, Osman MD ++; Neuberg, Gerald MD +; Miller, Leslie MD ++; Moses, Jeffery W. MD *+; Stone, Gregg W. MD *+; Giglio, James MD ++; Rabbani, LeRoy E. MD *+
|
Institution: | From the *Center for Interventional Vascular Therapy, +Cardiology Division, and ++Department of Emergency Medicine, Columbia University Medical Center, New York, NY.
|
Title: | |
Source: | Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 7(4):211-222, December 2008.
|
Abstract: | In 2003, we published our chest pain protocol for the management of acute coronary syndromes (ACSs) and acute myocardial infarction. Our algorithm was specifically designed for our institution, which was primary percutaneous coronary intervention (PCI) for all ST-elevation myocardial infarctions (STEMIs) and a preferred invasive approach for non-STEMIs. Since 2003, there have been numerous changes in the adjunctive pharmacotherapeutic armamentarium for PCI in both the STEMI and non-STEMI ACS context. We present our updated chest pain algorithm with a brief review of the rapidly evolving changes in adjunctive pharmacotherapy for PCI and provide a rationale for the changes that we have made to our institutional protocol. Clinical pathways need to be consistently updated and revises by incorporating new evidence from clinical trials in order to maintain clinical relevance.
(C) 2008 Lippincott Williams & Wilkins, Inc.
|
Author Keywords: | acute coronary syndromes; acute myocardial infarction; clinical pathways.
|
References: | 1.Biviano AB, Bergmann SR, Tenenbaum J, et al. Design of a comprehensive chest pain initiative in an academic urban hospital. Critic Pathw Cardiol. 2003;2:113-117.
2.Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297:1892-1900.
3.Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the management of patient with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing group to review new evidence and update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial infarction). Circulation. 2008;177:296-329.
4.Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). J AM Coll Cardiol. 2007;50:e1-e157.
5.Mehta SR, Yusuf S, Peters RJ, et al. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
6.Steinbuhl SR, Berger PB, Mann JT III, et al. CREDO investigators. Clopidogrel for the reduction of events during observation: early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
7.Sabatine MS, Cannon CP, Gibson CM, et al. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189.
8.Sabatine MS, Cannon CP, Gibson CM, et al. CLARITY-TIMI 28 investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics. The PCI CLARITY Study. JAMA. 2005;294:1224-1232.
9.Muller I, Seyfarth M, Rudiger S, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart. 2001;85:92-93.
10.Patti G, Colonna G, Pasceri V, et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention results from the ARMYDA-2 Study. Circulation. 2005;111:2099-2106.
11.Cuisset T, Frere C, Quilici J, et al. Benefit of a 600 mg loading dose on clopidopgrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol. 2006;48:1339-1345.
12.Hochholzer W, Trenk D, Frundi D, et al. Time dependence of platelet inhibition after a 600mh loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation. 2005;111:2560-2564.
13.Von Beckerath N, Taubert D, Pogatsa-Murray G, et al. Absorption, metabolization, and antiplatelet effects of 300mg, 600mg, and 900mg loading doses of clopidogrel. Results of the ISAR-CHOICE trial. Circulation. 2005;112:2946-2950.
14.Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203-2216.
15.Stone GW, Ware JH, Bertrand ME, et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one year results from the ACUITY trial. JAMA. 2007;298:2497-2506.
16.White HD, Chew DP, Hoekstra JW, et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2008;51:1734-1741.
17.Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218-2230.
18.Dangas GD, Guagliumi G, Witzenbichler B, et al. Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction: The HORIZONS AMI trial. Presented at: ACC 2008. Available at: http://www.TCTMD.com- ouverture dans une nouvelle fenêtre. Accessed April 12, 2008.
|
Language: | English.
|
Document Type: | Original Article.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 1535-282X
|
NLM Journal Code: | 101165286
|
DOI Number: | https://dx.doi.org/10.1097/HPC.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|